Alcon Investigative Site
Bloomington, Indiana, 47405, United States
NCT Number: NCT04013789
The purpose of this study was to compare the clinical performance of the new DAILIES® AquaComfort PLUS® FreshTech (DACP FreshTech) contact lenses to an already marketed daily disposable contact lens, DAILIES® AquaComfort PLUS® (DACP).
Looking for future studies?
Notify Me18 year–35 year
All sexes
Interventional
Not applicable
Bloomington, Indiana, 47405, United States
Subjects attended 4 scheduled visits for an expected duration of participation of 3 weeks.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Nelfilcon A soft contact lenses with a modified lens design
Other names: DAILIES® AquaComfort PLUS® FreshTech
Nelfilcon A soft contact lenses
Other names: DAILIES® AquaComfort PLUS®
Time frame: Week 1, each product
VA was assessed at a distance of 4 meters using a letter chart and was measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity.
Alcon Research
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05790928
Eye Diseases, Hyperopia
Tallahassee, Florida, United States
View Trial DetailsNCT07696468
Eye Diseases, Myopia
Guangzhou, Guangdong, China
View Trial DetailsNCT07512102
Eye Diseases, Myopia
Guangzhou, Guangdong, China
View Trial DetailsNCT07512115
Eye Diseases, Myopia
Guangzhou, Guangdong, China
View Trial Details